Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem versus meropenem in hospitalized children with complicated intra-abdominal infection
2009-015864-32Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Intra-abdominal infection (IAI) comparing Doripenem with Meropenem (2 arms). Primary endpoint: Safety and tolerability. Started Mar 2010; status: terminated.
02
Drugs
doripenemmeropenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2009-015864-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015864-32.